New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis
Clinical trial NCT00269438 · COMPLETED
Trial details
- NCT number
- NCT00269438
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2007-03-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.